%0 Journal Article %T Connecting Molecular Design with Patient-Level Treatment Decisions: An Integrative Review of Multimodal Foundation Models, Cross-Scale Biomedical Representations, and Evidence Gaps in Pharmaceutical and Precision Medicine Applications %A Michael Tan %A Farah Aziz %A Peter Nagy %A Johan de Vries %J Pharmacophore %@ 2229-5402 %D 2026 %V 17 %N 5 %R 10.51847/o6iDrAOuiq %P 82-91 %X Multimodal foundation models are expanding the range of biomedical information that artificial intelligence can represent, combining molecular structures, omic profiles, cellular states, medical images, and clinical records within increasingly general computational systems. However, the capacity to represent heterogeneous information does not establish that molecular design outputs can inform individualized treatment decisions. This integrative review examines the evidentiary connections between pharmaceutical discovery and precision-medicine applications, distinguishing computational representation, biological validation, clinical prediction, and treatment selection. The review combines molecular-design studies, biomedical foundation-model evaluations, multimodal integration research, pharmacological response models, and clinically oriented investigations. A bounded bibliographic search and structured evidence mapping inform the synthesis; complete database-wide screening and full-text inclusion denominators remain unresolved. Evidence is organized according to biomedical scale, representation type, validation setting, and the specific decision supported. The central contribution is a cross-scale interpretation that distinguishes directly evaluated connections from relationships inferred through adjacent studies and transitions that remain untested. Molecular and cellular models provide increasingly sophisticated representations, while clinical investigations demonstrate selected routes from patient profiling to treatment matching. Evidence connecting these capabilities within a single prospectively validated molecular-design-to-treatment system remains more limited.  The review identifies the methodological and translational conditions under which multimodal representations could become clinically actionable, emphasizing biological context, independent validation, comparative treatment evidence, and preservation of uncertainty across successive scales. %U https://pharmacophorejournal.com/article/connecting-molecular-design-with-patient-level-treatment-decisions-an-integrative-review-of-multimo-d2a8auyts3iboyp